Sourat Darabi, David R. Braxton, Carlos E. Zuazo, Michael J. Demeure. "Reflexed molecular testing to identify patients with biomarkers associated with tumor-agnostic FDA drug approvals.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e15160